![]() ![]() | [Frontiers in Bioscience 2, d12-26, January 1, 1997] Reprints PubMed CAVEAT LECTOR |
|
![]() ![]() ![]()
|
CYTOKINES IN ACUTE AND CHRONIC INFLAMMATION Carol A. Feghali, Ph.D., and Timothy M. Wright, M.D. Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh, E1109 Biomedical Science Tower, 200 Lothrop St., Pittsburgh, PA 15261
Received 11/06/96; Accepted 12/13/96; On-line 01/01/97
![]() 1. J.I. Gallin, I.M. Goldstein, R. Snyderman, editors: Inflammation. Basic principles and clinical correlates, ed 2, New York, Raven Press (1992) 2. J.S. Warren: Interleukins and tumor necrosis factor in inflammation. Crit Rev Clin Lab Sci 28,37-59 (1990) 3. C.A. Dinarello: Reduction of inflammation by decreasing production of interleukin-1 or by specific receptor antagonism. Int J Tiss Reac 14, 65-75 (1992) 4. C.A. Dinarello: Interleukin-1. In: The cytokine handbook. Ed: Thomson A., Academic Press, San Diego, CA (1994) 5. J. Vilcek, T.H. Lee: Tumor necrosis factor. J Biol Chem 266, 7313-16 (1991) 6. R.A. Smith & C.Baglioni: The active form of tumor necrosis factor is a trimer. J Biol Chem 262, 6951-4 (1987) 7. B.B. Aggarwal: Tumor Necrosis Factor. In: Human cytokines. Eds: Aggarwal B.B., Gutterman J.U., Blackwell Scientific Publications, Boston, MA (1992) 8. B. Beutler & A. Cerami: The common mediator of shock, cachexia, and tumor necrosis. Adv Immunol 42, 213-31 (1988) 9. N.L. Paul & N.H. Ruddle: Lymphotoxin. Ann Rev Immunol 6, 407-38 (1988) 10. T. Miethke, H. Gaus, C. Wahl, K. Heeg & H. Wagner: T-cell-dependent shock induced by a bacterial superantigen. Chem Immunol 55, 172-84 (1992) 11. T. Miethke, C. Wahl, K. Heeg, B. Echtenacher, P.H. Krammer & H. Wagner: T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor. J Exp Med 175, 91-8 (1992) 12. J. Van Snick: Interleukin-6: an overview. Ann Rev Immunol 8, 253-78 (1990) 13. T. Hirano: The biology of interleukin-6. Chem Immunol 51, 153-80 (1992) 14. T. Hirano, T. Taga, T. Matsuda, M. Hibi, S. Suematsu, B. Tang, M. Murakami & T. Kishimoto: Interleukin 6 and its receptor in the immune response and hematopoiesis. Int J Cell Cloning 8, 155-66 (1990) 15. T. Hirano: Interleukin-6 and its relation to inflammation and disease. Clin Immunol Immunopathol 62, S60-5 (1992) 16. P.L.J. Tan, S. Farmiloe, S. Yeoman & J.D. Watson: Expression of the interleukin 6 gene in rheumatoid synovial fibroblasts. J Rheumatol 17, 1608-12 (1990) 17. C.A. Feghali, K.L. Bost, D.W. Boulware & L.S. Levy: Mechanisms of pathogenesis in scleroderma. I. Overproduction of IL-6 by fibroblasts cultured from affected skin sites of patients with scleroderma. J Rheumatol 19, 1207-11 (1992) 18. S.R. Paul & P. Schendel: The cloning and biological characterization of recombinant human interleukin 11. Int J Cell Cloning 10, 135-43 (1992) 19. H. Baumann & P. Schendel: Interleukin-11 regulates the hepatic expression of the same plasma protein genes as interleukin-6. J Biol Chem 266, 20424-27 (1991) 20. M.D. Miller & M.S. Krangel: Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines, Crit Rev Immunol 12, 17-46 (1992) 21. M.Y. Stoeckle & K.A. Barker: Two burgeoning families of platelet factor 4-related proteins: mediators of the inflammatory response, New Biologist 2, 313-23 (1990) 22. R.M. Strieter, T.J. Standiford, G.B. Huffnagle, L.M. Colletti, N.W. Lukacs & S.L. Kunke: "The Good, the Bad, and the Ugly." The role of chemokines in models of human disease. J Immunol 156, 3583-86 (1996) 23. M. Baggiolini & I. Clark-Lewis: Interleukin-8, a chemotactic and inflammatory cytokine. FEBS Lett 307, 97-101 (1992) 24. J. Van Damme: Interleukin-8 and related chemotactic cytokines. In: The Cytokine Handbook. Ed: Thomson A., Academic Press, San Diego, CA (1994) 25. A.R. Huber, S.L. Kunkel, R.F. Todd 3d & S.J. Weiss: Regulation of transendothelial neutrophil migration by endogenous interleukin-8. Science 254, 99-102 (1991) 26. M. Seitz, B. Dewald, M. Ceska, N. Gerber & M. Baggiolini: Interleukin-8 in inflammatory rheumatic diseases: synovial fluid levels, relation to rheumatoid factors, production by mononuclear cells, and effects of gold sodium thiomalate and methotrexate. Rheumatol Int 12, 159-64 (1992) 27. Y.R. Mahida, M. Ceska, F. Effenberger, L. Kurlak, I. Lindley & C.J. Hawkey: Enhanced synthesis of neutrophil-activating peptide-1/ interleukin-8 in active ulcerative colitis. Clin Sci 82, 273-5 (1992) 28. S.L. Kunkel, N. Lukacs, T. Kasama & R.M. Strieter: The role of chemokines in inflammatory joint disease. J Leukoc Biol 58, 6-12 (1996) 29. E.A. Garcia-Zepeda, M.E. Rothenberg, R.T. Ownbey, J. Celestin, P. Leder & A.D. Luster: Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nature Med 2, 449-56 (1996) 30. S. Laberge, W.W. Cruikshank, D.J. Beer & D.M. Center: Secretion of IL-16 (Lymphocyte chemoattractant factor) from serotonin-stimulated CD8+ T cells in vitro. J Immunol 156, 310-15 (1996) 31. W.W. Cruikshank, D.M. Center, N. Nisar, M. Wu, B. Natke, A.C. Theodore & H. Kornfeld: Molecular and functional analysis of a lymphocyte chemoattractant factor. Association of biologic function with CD4 expression. Proc Natl Acad Sci USA 91, 5109-13 (1994) 32. G.S. Kelner, J. Kennedy, K.B. Bacon, S. Kleyensteuber, D.A. Largaespada, N.A. Jenkins, N.G. Copeland, J.F. Bazan, K.W. Moore, T.J. Schall & A. Zlotnik: Lymphotactin: a cytokine that represents a new class of chemokine. Science 266, 1395-9 (1994) 33. W.W. Cruikshank, A. Long, R.E. Tarpy, H. Kornfeld, M.P. Carroll, L. Teran, S.T. Holgate & D.M. Center: Early identification of interleukin-16 (lymphocyte chemoattractant factor) and macrophage inflammatory protein 1 alpha (MIP-1alpha) in bronchoalveolar lavage fluid of antigen-challenged asthmatics. Am J Resp Cell Mol Biol 13, 738-47 (1995) 34. Z. Yao, S.L. Painter, W.C. Fanslow, D. Ulrich, B.M. Macduff, M.K. Spriggs & R.J. Armitage: Human IL-17: a novel cytokine derived from T cells. J Immunol 155, 5483-6 (1995) 35. D. Metcalf: The colony stimulating factors. Discovery, development, and clinical applications. Cancer 65, 2185-95 (1990) 36. S. Nagata: Granulocyte colony stimulating factor and its receptor. In: The Cytokine Handbook. Ed: Thomson A., Academic Press, San Diego, CA (1994) 37. J.P. Arm & T.H. Lee: The pathobiology of bronchial asthma. Adv Immunol 51, 323-82 (1992) 38. K. Koike, M. Ogawa, J.N. Ihle, T. Miyake, T. Shimizu, A. Miyajima, T. Yokota & K-I. Arai: Recombinant murine granulocyte-macrophage (GM) colony-stimulating factor supports formation of GM and multipotential blast cell colonies in culture: comparison with the effects of interleukin-3. J Cell Physiol 131, 458-64 (1987) 39. J.W. Schrader: Interleukin-3. In: The Cytokine Handbook. Ed: Thomson A., Academic Press, San Diego, CA (1994) 40. K.-I. Arai, F. Lee, A. Miyajima, S. Miyatake, N. Arai & T. Yokota: Cytokines: coordinators of immune and inflammatory responses. Ann Rev Biochem 59, 783-836 (1991) 41. P.S.Crosier & S.C. Clark: Basic biology of the hematopoietic growth factors. Semin Oncol 19, 349-61 (1992) 42. M.P. Beckmann, D. Cosman, W. Fanslow, C.R. Maliszewski & S.D. Lyman: The interleukin-4 receptor: structure, function, and signal transduction. Chem Immunol 51, 107-34 (1992) 43. T. Yokota, N. Arai, J. De Vries, H. Spits, J. Banchereau, A. Zlotnik, D. Rennick, M. Howard, Y. Takebe, S. Miyatake, F. Lee & K-I. Arai: Molecular biology of interleukin 4 and interleukin 5 genes and biology of their products that stimulate B cells, T cells, and hemopoietic cells. Immunol Rev 102, 137-87 (1988) 44. R. Kuhn, K. Rajewsky & W. Muller: Generation and analysis of interleukin-4 deficient mice. Science 254, 707-10 (1991) 45. C. Fertin, J.F. Nicolas, P. Gillery, B. Kalis, J. Banchereau & F.X. Maquart: Interleukin-4 stimulates collagen synthesis by normal and scleroderma fibroblasts in dermal equivalents. Cell Mol Biol 37, 823-9 (1991) 46. C.A. Feghali, K.L. Bost, D.W. Boulware & L.S. Levy: Human recombinant interleukin-4 induces proliferation and interleukin-6 production by cultured human skin fibroblasts. Clin Immunol Immunopathol 63, 182-7 (1992) 47. P. Miossec: Interleukin 4. A potential anti-inflammatory agent. Rev Rheum 60, 119-24 (1993) 48. R.G. Goodwin, S. Lupton, A. Schmierer, K.J. Hjerrild, R. Jerzy, W. Clevenger, S. Gillis, D. Cosman & A.E. Namen: Human interleukin-7: molecular cloning and growth factor activity on human and murine B-lineage cells. Proc Natl Acad Sci USA 86, 302-6 (1989) 49. J. Van Snick, A. Goethals, J.C. Renauld, E. Van Roost, C. Uyttenhove, M.R. Rubira, R.L. Moritz & R.J. Simpson: Cloning and characterization of a cDNA for a new mouse T cell growth factor (P40). J Exp Med 169, 363-8 (1989) 50. Y.C. Yang, S. Ricciardi, A. Ciarletta, J. Calvetti, K. Kelleher & S.C. Clark: Expression cloning of cDNA encoding a novel human hematopoietic growth factor: human homolog of murine T-cell growth factor P40. Blood 74, 1880-4 (1989). 51. K. Kelleher, K. Bean, S.C. Clark, W.Y. Leung, T.L. Yang-Feng, J.W. Chen, P.F. Lin , W. Luo & Y.C. Yang YC: Human interleukin-9: genomic sequence, chromosomal location, and sequences essential for its expression in human T-cell leukemia virus (HTLV)-I-transformed human T cells. Blood 77, 1436-41 (1991) 52. F.A. Houssiau, J.C. Renauld, W.E. Fibbe & J. Van Snick: IL-2 dependence of IL-9 expression in human T lymphocytes. J Immunol 148, 3147-51 (1992) 53. M.C. Cohen & S. Cohen: Cytokine Function. A study in biologic diversity. Am J Clin Pathol 105, 589-98 (1996) 54. W.F. Chen & A. Zlotnik: IL-10: a novel cytotoxic T cell differentiation factor. J Immunol 147, 528-34 (1991) 55. R. de Waal Malefyt, H. Yssel, M.G. Roncarolo, H. Spits & J.E. de Vries: Interleukin-10. Curr Opin Immunol 4, 314-20 (1992) 56. T.R. Mosmann & K.W. Moore: The role of IL-10 in crossregulation of TH1 and TH2 responses. Immunol Today 12, A49-53 (1991) 57. K.W. Moore, P. Vieira, D.F. Fiorentino, M.L. Troustine, T.A. Khan & T.R. Mosmann: Homology of cytokine synthesis inhibitory factor (IL10) to the Epstein-Barr virus gene BCRF1. Science 248, 1230-4 (1990) 58. T.R. Mosmann: Interleukin-10. In: The Cytokine Handbook. Ed: Thomson A., Academic Press, San Diego, CA (1994) 59. K.D. Brown, S.M. Zurawski, T.R. Mosmann & G. Zurawski: A family of small inducible proteins secreted by leukocytes are members of a new superfamily that includes leukocyte and fibroblast-derived inflammatory agents, growth factors, and indicators of various activation processes. J Immunol 142, 679-87 (1989)
60. A. Minty, P. Chalon, J.M. Derocq, X. Dumont, J.C. Guillemot, M. Kaghad, C. Labit, P. Leplatois, P. Liauzun, B. Miloux, C. Minty, P. Casellas, G. Loison, J. Lupker, D. Shire, P. Ferrara & D. Caput: Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 362, 248-50 (1993) 61. J. Punnonen, G. Aversa, B.G. Cocks, A.N. McKenzie, S. Menon, G. Zurawski, R. de Waal Malefyt & J.E. de Vries JE: Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc Natl Acad Sci USA 90, 3730-4 (1993) 62. R. Ford, A. Tamayo, B. Martin, K. Niu, K. Claypool, F. Cabanillas & J. Ambrus Jr: Identification of B-cell growth factors (interleukin-14; high molecular weight-B-cell growth factors) in effusion fluids from patients with aggressive B-cell lymphomas. Blood 86, 283-93 (1995) 63. W.A. Border & E. Ruoslahti: Transforming growth factor-ß in disease: the dark side of tissue repair. J Clin Invest 90, 1-7 (1992) 64. M.B. Sporn, A.B. Roberts, L.M. Wakefield & R.K. Assoian RK: Transforming growth factor-ß: biological function and chemical structure. Science 233, 532-4 (1986) 65. W.O. Cooper, R.A. Fava, C.A. Gates, M.A. Cremer & A.S. Townes: Acceleration of onset of collagen-induced arthritis by intra-articular injection of tumour necrosis factor or transforming growth factor-beta. Clin Exp Immunol 89, 244-50 (1992) 66. H.G. Herrod: Interleukins in immunologic and allergic diseases. Ann Allergy 63, 269-72 (1989) 67. M.K. Gately, A.G. Wolitzky, P.M. Quinn & R. Chizzonite: Regulation of human cytolytic lymphocyte responses by interleukin-12. Cell Immunol 143, 127-42 (1992) 68. M. Kiniwa, M. Gately, U. Gubler, R. Chizzonite, C. Fargeas & G. Delespesse: Recombinant interleukin-12 suppresses the synthesis of immunoglobulin E by interleukin-4 stimulated human lymphocytes. J Clin Invest 90, 262-6 (1992) 69. P. Scott: IL-12: initiation cytokine for cell-mediated immunity. Science 260, 496-7 (1993) 70. J.G. Giri, D.M. Anderson, S. Kumaki, L.S. Park, K.H. Grabstein & D. Cosman: IL-15, a novel T cell growth factor that shares activities and receptor components with IL-2. J Leukoc Biol 57, 763-6 (1995) 71. T.M. Doherty, R.A. Seder & A. Sher: Induction and regulation of IL-15 expression in murine macrophages. J Immunol 156, 735-41 (1996) 72. I.B. McInnes, J. Al-Mughales, M. Field, B.P. Leung, F.P. Huang, R. Dixon, R.D. Sturrock, P.C. wilkinson & F.Y. Liew: The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis. Nature Med 2, 175-82 (1996) 73. E.F. Wheelock: Interferon-like virus-inhibitor induced in human leukocytes by phytohemagglutinin. Science 149, 310-11 (1965) 74. E. De Maeyer & J. De Maeyer-Guignard: Interferons. In: The Cytokine Handbook. Ed: Thomson A., Academic Press, San Diego, CA (1994) 75. H. Heremans & A. Billiau: The potential role of interferons and interferon antagonists in inflammatory disease. Drugs 38, 957-72 (1989) 76. C.O. Jacob, P.H. van der Meide & H.O. McDevitt: In vivo treatment of (NZB x NZW)F1 lupus-like nephritis with monoclonal antibody to g interferon. J Exp Med 166, 798-803 (1987) 77. I.L. Campbell, L. Oxbrow, M. Koulmanda & L.C. Harrison: IFN-gamma induces islet cell MHC antigens and enhances autoimmune, streptozotocin-induced diabetes in the mouse. J Immunol 140, 1111-6 (1988) 78. N. Sarvetnick, D. Liggitt, S.L. Pitts, S.E. Hansen & T.A. Stewart: Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma. Cell 52, 773-82 (1988) 79. N.J. Mauritz, R. Holdmdahl, R. Jonsson, P.H. van der Meide, A. Scheynius & L. Klareskog: Treatment with gamma-interferon triggers the onset of collagen arthritis in mice. Arthritis Rheum 31, 1297-1304 (1988) 80. G.E. Grau, H. Heremans, P.F. Piguet, P. Pointaire, P.H. Lambert, A. Billiau & P. Vassalli: Monoclonal antibody against interferon gamma can prevent experimental cerebral malaria and its associated overproduction of tumor necrosis factor. Proc Natl Acad Sci USA 86, 55724 (1989) 81. D.K. Dalton, S. Pitts-Meek, S. Keshav, I.S. Figari, A. Bradley & T.A. Stewart: Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 259, 1739-42 (1993) 82. H. Okamura, H. Tsutsui, T. Komatsu, M. Yutsudo, A. Hakura, T. Tanimoto, K. Torigoe, T. Okura, Y. Nukada, K. Hattori, K. Akita, M. Namba, F. Tanabe, K. Konishi, S. Fukuda, & M. Kurimoto: Cloning of a new cytokine that induces IFN-gamma production by T cells. Science 378, 88-91 (1995) 83. S. Ushio, M. Namba, T. Okura, K. Hattori, Y. Nukada, K. Akita, F. Tanabe, K. Konishi, M. Micallef, M. Fuji, K. Torigoe, T. Tanimoto, S. Fukuda, M. Ikeda, H. Okamura, & M. Kurimoto: Cloning of the cDNA for human IFN-gamma-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. J Immunol 156, 4274-9 (1996) 84. T. Kishimoto, S. Akira & T. Taga: Interleukin-6 and its receptor: a paradigm for cytokines. Science 258, 593-7 (1992) 85. W.C. Greene: The human interleukin-2 receptor. Ann Rev Immunol 4, 69-95 (1986) 86. K.A. Smith: The two-chain structure of high-affinity IL-2 receptors. Immunol Today 8, 11-13 (1987) 87. M.N. Manoussakis, G.K. Papadopoulos, A.A. Drosos & H.M. Moutsopoulos: Soluble interleukin 2 receptor molecules in the serum of patients with autoimmune diseases. Clin Immunol Immunopathol 50, 321-32 (1989) 88. T. Taga, M. Hibi, M. Murakami, M. Saito, H. Yawata, M. Narazaki, Y. Hirata, T. Sugita, K. Yasukawa, T. Hirano & T. Kishimoto: Interleukin-6 receptor and signals. Chem Immunol 51, 181-204 (1992) 89. J.F. Bazan: Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci USA 87, 6934-8 (1990) 90. A. Oehm, I. Behrmann, W. Falk, M. Pawlita, G. Maier, C. Klas, M. Li-Weber, S. Richards, J. Dhein, B.C. Trauth, H. Ponstingl & P.H. Krammer: Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily: sequence identity with the Fas antigen. J Biol Chem 267, 10709-15 (1992) 91. J. Banchereau, F. Bazan, D. Blanchard, F. Briere, J.P. Galizzi, C. van Kooten, Y.J. Liu, F. Rousset, & S. Saeland: The CD40 antigen and its ligand. Ann Rev Immunol 12, 881-922 (1994) 92. L.A. Tartaglia & D.V. Goeddel: Two TNF receptors. Immunol Today 13, 151-3 (1992) 93. K. Wiegmann, S. Schutze, E. Kampen, A. Himmler, T. Machleidt & M. Kronke: Human 55-kDa receptor for tumor necrosis factor coupled to signal transduction cascades. J Biol Chem 267, 17997-8001 (1992) 94. T.N.C. Wells, C.A. Power, M. Lusti-Narasimhan, A.J. Hoogewerf, R.M. Cooke, C. Chung, M.C. Peitsch & A.E.I. Proudfoot: Selectivity and antagonism of chemokine receptors. J Leukoc Biol 59, 53-60 (1996) 95. C.J. Raport, V.L. Schweickart, D. Chantry, R.L. Eddy Jr., T.B. Shows, R. Godiska & P.W. Gray: New members of the chemokine receptor gene family. J Leuko. Biol 59, 18-23 (1996) 96. P. Bates: Chemokine receptors and HIV-1: an attractive pair? Cell 86, 1-3 (1996) 97. M. Dean, M. Carrington, C. Winkler, G.A. Huttley, M.W. Smith, R. Allidmets, J.I. Goedert, S.P. Buchbinder, E. Vittinghoff, E. Gomperts, S. Donfield, D. Vlahov, R. Kaslow, A. Saah, C. Rinaldo & R. Detels: Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR-5 structural gene. Science 273, 1856-62 (1996) |